APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Politically Exposed Persons (PEP) Screening

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Politically Exposed Persons (PEP) Screening Market Outlook and Growth Opportunities 2026

Report ID 174217270411 April 2026Not stated

Choose your research edition.

Industry ResearchPolitically Exposed Persons (PEP) Screening Industry Research Report 2026140 pages · $2,950 USDIndustry Growth & TrendsGlobal Politically Exposed Persons (PEP) Screening Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Politically Exposed Persons (PEP) Screening Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Politically Exposed Persons (PEP) Screening Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Politically Exposed Persons (PEP) Screening Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Politically Exposed Persons (PEP) Screening market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Politically Exposed Persons (PEP) Screening is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Politically Exposed Persons (PEP) Screening is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Politically Exposed Persons (PEP) Screening is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Politically Exposed Persons (PEP) Screening market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Politically Exposed Persons (PEP) Screening market include IDnow, Jumio, Persona, Entrust, Smile ID, Veriff, Trulioo, GBG Plc and Sumsub, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Politically Exposed Persons (PEP) Screening market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Politically Exposed Persons (PEP) Screening and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Politically Exposed Persons (PEP) Screening revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Politically Exposed Persons (PEP) Screening market.

Politically Exposed Persons (PEP) Screening Segment by Company

IDnow

Jumio

Persona

Entrust

Smile ID

Veriff

Trulioo

GBG Plc

Sumsub

Ondato

NameScan

Castellum.AI

Dotfile

RELX (LexisNexis)

Owlin

Dilisense GmbH

Fenergo

Thirdfort

Experian

AU10TIX

Politically Exposed Persons (PEP) Screening Segment by Type

Software

Service

Politically Exposed Persons (PEP) Screening Segment by Application

BFSI

iGaming

Payments

eCommerce

Other

Politically Exposed Persons (PEP) Screening Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Politically Exposed Persons (PEP) Screening status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Politically Exposed Persons (PEP) Screening key companies, revenue, market share, and recent developments.

3. To split the Politically Exposed Persons (PEP) Screening breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Politically Exposed Persons (PEP) Screening market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Politically Exposed Persons (PEP) Screening significant trends, drivers, influence factors in global and regions.

6. To analyze Politically Exposed Persons (PEP) Screening competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Politically Exposed Persons (PEP) Screening market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Politically Exposed Persons (PEP) Screening and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Politically Exposed Persons (PEP) Screening.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Politically Exposed Persons (PEP) Screening industry.

Chapter 3: Detailed analysis of Politically Exposed Persons (PEP) Screening company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Politically Exposed Persons (PEP) Screening in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Politically Exposed Persons (PEP) Screening in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Politically Exposed Persons (PEP) Screening Industry Trends Table 2. Politically Exposed Persons (PEP) Screening Industry Drivers Table 3. Politically Exposed Persons (PEP) Screening Industry Opportunities and Challenges Table 4. Politically Exposed Persons (PEP) Screening Industry Restraints Table 5. Global Politically Exposed Persons (PEP) Screening Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Politically Exposed Persons (PEP) Screening Revenue Share by Company (2021-2026) Table 7. Global Politically Exposed Persons (PEP) Screening Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Politically Exposed Persons (PEP) Screening Key Company Manufacturing Base & Headquarters Table 9. Global Politically Exposed Persons (PEP) Screening Company, Product Type & Application Table 10. Global Politically Exposed Persons (PEP) Screening Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Politically Exposed Persons (PEP) Screening by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Software Table 15. Significant Companies of Service Table 16. Global Politically Exposed Persons (PEP) Screening Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Politically Exposed Persons (PEP) Screening Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Politically Exposed Persons (PEP) Screening Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Politically Exposed Persons (PEP) Screening Sales Value Share by Type (2021-2026) Table 20. Global Politically Exposed Persons (PEP) Screening Sales Value Share by Type (2027-2032) Table 21. Significant Companies of BFSI Table 22. Significant Companies of iGaming Table 23. Significant Companies of Payments Table 24. Significant Companies of eCommerce Table 25. Significant Companies of Other Table 26. Global Politically Exposed Persons (PEP) Screening Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Politically Exposed Persons (PEP) Screening Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Politically Exposed Persons (PEP) Screening Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Politically Exposed Persons (PEP) Screening Sales Value Share by Application (2021-2026) Table 30. Global Politically Exposed Persons (PEP) Screening Sales Value Share by Application (2027-2032) Table 31. Global Politically Exposed Persons (PEP) Screening Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Politically Exposed Persons (PEP) Screening Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Politically Exposed Persons (PEP) Screening Sales Value Share by Region (2021-2026) Table 34. Global Politically Exposed Persons (PEP) Screening Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Politically Exposed Persons (PEP) Screening Sales Value Share by Region (2027-2032) Table 36. Global Politically Exposed Persons (PEP) Screening Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Politically Exposed Persons (PEP) Screening Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Politically Exposed Persons (PEP) Screening Sales Value Market Share by Country (2021-2026) Table 39. Global Politically Exposed Persons (PEP) Screening Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Politically Exposed Persons (PEP) Screening Sales Value Market Share by Country (2027-2032) Table 41. IDnow Company Information Table 42. IDnow Business Overview Table 43. IDnow Politically Exposed Persons (PEP) Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. IDnow Politically Exposed Persons (PEP) Screening Product Portfolio Table 45. IDnow Recent Development Table 46. Jumio Company Information Table 47. Jumio Business Overview Table 48. Jumio Politically Exposed Persons (PEP) Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Jumio Politically Exposed Persons (PEP) Screening Product Portfolio Table 50. Jumio Recent Development Table 51. Persona Company Information Table 52. Persona Business Overview Table 53. Persona Politically Exposed Persons (PEP) Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Persona Politically Exposed Persons (PEP) Screening Product Portfolio Table 55. Persona Recent Development Table 56. Entrust Company Information Table 57. Entrust Business Overview Table 58. Entrust Politically Exposed Persons (PEP) Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Entrust Politically Exposed Persons (PEP) Screening Product Portfolio Table 60. Entrust Recent Development Table 61. Smile ID Company Information Table 62. Smile ID Business Overview Table 63. Smile ID Politically Exposed Persons (PEP) Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Smile ID Politically Exposed Persons (PEP) Screening Product Portfolio Table 65. Smile ID Recent Development Table 66. Veriff Company Information Table 67. Veriff Business Overview Table 68. Veriff Politically Exposed Persons (PEP) Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Veriff Politically Exposed Persons (PEP) Screening Product Portfolio Table 70. Veriff Recent Development Table 71. Trulioo Company Information Table 72. Trulioo Business Overview Table 73. Trulioo Politically Exposed Persons (PEP) Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Trulioo Politically Exposed Persons (PEP) Screening Product Portfolio Table 75. Trulioo Recent Development Table 76. GBG Plc Company Information Table 77. GBG Plc Business Overview Table 78. GBG Plc Politically Exposed Persons (PEP) Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. GBG Plc Politically Exposed Persons (PEP) Screening Product Portfolio Table 80. GBG Plc Recent Development Table 81. Sumsub Company Information Table 82. Sumsub Business Overview Table 83. Sumsub Politically Exposed Persons (PEP) Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Sumsub Politically Exposed Persons (PEP) Screening Product Portfolio Table 85. Sumsub Recent Development Table 86. Ondato Company Information Table 87. Ondato Business Overview Table 88. Ondato Politically Exposed Persons (PEP) Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Ondato Politically Exposed Persons (PEP) Screening Product Portfolio Table 90. Ondato Recent Development Table 91. NameScan Company Information Table 92. NameScan Business Overview Table 93. NameScan Politically Exposed Persons (PEP) Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. NameScan Politically Exposed Persons (PEP) Screening Product Portfolio Table 95. NameScan Recent Development Table 96. Castellum.AI Company Information Table 97. Castellum.AI Business Overview Table 98. Castellum.AI Politically Exposed Persons (PEP) Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Castellum.AI Politically Exposed Persons (PEP) Screening Product Portfolio Table 100. Castellum.AI Recent Development Table 101. Dotfile Company Information Table 102. Dotfile Business Overview Table 103. Dotfile Politically Exposed Persons (PEP) Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Dotfile Politically Exposed Persons (PEP) Screening Product Portfolio Table 105. Dotfile Recent Development Table 106. RELX (LexisNexis) Company Information Table 107. RELX (LexisNexis) Business Overview Table 108. RELX (LexisNexis) Politically Exposed Persons (PEP) Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. RELX (LexisNexis) Politically Exposed Persons (PEP) Screening Product Portfolio Table 110. RELX (LexisNexis) Recent Development Table 111. Owlin Company Information Table 112. Owlin Business Overview Table 113. Owlin Politically Exposed Persons (PEP) Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Owlin Politically Exposed Persons (PEP) Screening Product Portfolio Table 115. Owlin Recent Development Table 116. Dilisense GmbH Company Information Table 117. Dilisense GmbH Business Overview Table 118. Dilisense GmbH Politically Exposed Persons (PEP) Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Dilisense GmbH Politically Exposed Persons (PEP) Screening Product Portfolio Table 120. Dilisense GmbH Recent Development Table 121. Fenergo Company Information Table 122. Fenergo Business Overview Table 123. Fenergo Politically Exposed Persons (PEP) Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Fenergo Politically Exposed Persons (PEP) Screening Product Portfolio Table 125. Fenergo Recent Development Table 126. Thirdfort Company Information Table 127. Thirdfort Business Overview Table 128. Thirdfort Politically Exposed Persons (PEP) Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Thirdfort Politically Exposed Persons (PEP) Screening Product Portfolio Table 130. Thirdfort Recent Development Table 131. Experian Company Information Table 132. Experian Business Overview Table 133. Experian Politically Exposed Persons (PEP) Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Experian Politically Exposed Persons (PEP) Screening Product Portfolio Table 135. Experian Recent Development Table 136. AU10TIX Company Information Table 137. AU10TIX Business Overview Table 138. AU10TIX Politically Exposed Persons (PEP) Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. AU10TIX Politically Exposed Persons (PEP) Screening Product Portfolio Table 140. AU10TIX Recent Development Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Politically Exposed Persons (PEP) Screening Product Image Figure 2. Global Politically Exposed Persons (PEP) Screening Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Politically Exposed Persons (PEP) Screening Market Size (2021-2032) & (US$ Million) Figure 4. Global Politically Exposed Persons (PEP) Screening Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Software Image Figure 8. Service Image Figure 9. Global Politically Exposed Persons (PEP) Screening Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Politically Exposed Persons (PEP) Screening Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Politically Exposed Persons (PEP) Screening Sales Value Share by Type (2021-2032) Figure 12. BFSI Image Figure 13. iGaming Image Figure 14. Payments Image Figure 15. eCommerce Image Figure 16. Other Image Figure 17. Global Politically Exposed Persons (PEP) Screening Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Politically Exposed Persons (PEP) Screening Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Politically Exposed Persons (PEP) Screening Sales Value Share by Application (2021-2032) Figure 20. Global Politically Exposed Persons (PEP) Screening Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Politically Exposed Persons (PEP) Screening Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Politically Exposed Persons (PEP) Screening Sales Value (2021-2032) & (US$ Million) Figure 23. North America Politically Exposed Persons (PEP) Screening Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Politically Exposed Persons (PEP) Screening Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Politically Exposed Persons (PEP) Screening Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Politically Exposed Persons (PEP) Screening Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Politically Exposed Persons (PEP) Screening Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Politically Exposed Persons (PEP) Screening Sales Value (2021-2032) & (US$ Million) Figure 29. South America Politically Exposed Persons (PEP) Screening Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Politically Exposed Persons (PEP) Screening Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Politically Exposed Persons (PEP) Screening Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Software
  • Service
Applications
  • BFSI
  • iGaming
  • Payments
  • eCommerce
  • Other
Companies covered
  • IDnow
  • Jumio
  • Persona
  • Entrust
  • Smile ID
  • Veriff
  • Trulioo
  • GBG Plc
  • Sumsub
  • Ondato
  • NameScan
  • Castellum.AI
  • Dotfile
  • RELX (LexisNexis)
  • Owlin
  • Dilisense GmbH
  • Fenergo
  • Thirdfort
  • Experian
  • AU10TIX

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Politically Exposed Persons (PEP) Screening Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Politically Exposed Persons (PEP) Screening Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Politically Exposed Persons (PEP) Screening Market Dynamics
  1. 2.1 Politically Exposed Persons (PEP) Screening Industry Trends
  2. 2.2 Politically Exposed Persons (PEP) Screening Industry Drivers
  3. 2.3 Politically Exposed Persons (PEP) Screening Industry Opportunities and Challenges
  4. 2.4 Politically Exposed Persons (PEP) Screening Industry Restraints
3 Politically Exposed Persons (PEP) Screening Market by Company
  1. 3.1 Global Politically Exposed Persons (PEP) Screening Company Revenue Ranking in 2025
  2. 3.2 Global Politically Exposed Persons (PEP) Screening Revenue by Company (2021-2026)
  3. 3.3 Global Politically Exposed Persons (PEP) Screening Company Ranking (2024-2026)
  4. 3.4 Global Politically Exposed Persons (PEP) Screening Company Manufacturing Base and Headquarters
  5. 3.5 Global Politically Exposed Persons (PEP) Screening Company Product Type and Application
  6. 3.6 Global Politically Exposed Persons (PEP) Screening Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Politically Exposed Persons (PEP) Screening Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Politically Exposed Persons (PEP) Screening Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Politically Exposed Persons (PEP) Screening Market by Type
  1. 4.1 Politically Exposed Persons (PEP) Screening Type Introduction
  2. 4.1.1 Software
  3. 4.1.2 Service
  4. 4.2 Global Politically Exposed Persons (PEP) Screening Sales Value by Type
  5. 4.2.1 Global Politically Exposed Persons (PEP) Screening Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Politically Exposed Persons (PEP) Screening Sales Value by Type (2021-2032)
  7. 4.2.3 Global Politically Exposed Persons (PEP) Screening Sales Value Share by Type (2021-2032)
5 Politically Exposed Persons (PEP) Screening Market by Application
  1. 5.1 Politically Exposed Persons (PEP) Screening Application Introduction
  2. 5.1.1 BFSI
  3. 5.1.2 iGaming
  4. 5.1.3 Payments
  5. 5.1.4 eCommerce
  6. 5.1.5 Other
  7. 5.2 Global Politically Exposed Persons (PEP) Screening Sales Value by Application
  8. 5.2.1 Global Politically Exposed Persons (PEP) Screening Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Politically Exposed Persons (PEP) Screening Sales Value by Application (2021-2032)
  10. 5.2.3 Global Politically Exposed Persons (PEP) Screening Sales Value Share by Application (2021-2032)
6 Politically Exposed Persons (PEP) Screening Regional Value Analysis
  1. 6.1 Global Politically Exposed Persons (PEP) Screening Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Politically Exposed Persons (PEP) Screening Sales Value by Region (2021-2032)
  3. 6.2.1 Global Politically Exposed Persons (PEP) Screening Sales Value by Region: 2021-2026
  4. 6.2.2 Global Politically Exposed Persons (PEP) Screening Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Politically Exposed Persons (PEP) Screening Sales Value (2021-2032)
  7. 6.3.2 North America Politically Exposed Persons (PEP) Screening Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Politically Exposed Persons (PEP) Screening Sales Value (2021-2032)
  10. 6.4.2 Europe Politically Exposed Persons (PEP) Screening Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Politically Exposed Persons (PEP) Screening Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Politically Exposed Persons (PEP) Screening Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Politically Exposed Persons (PEP) Screening Sales Value (2021-2032)
  16. 6.6.2 South America Politically Exposed Persons (PEP) Screening Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Politically Exposed Persons (PEP) Screening Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Politically Exposed Persons (PEP) Screening Sales Value Share by Country, 2025 VS 2032
7 Politically Exposed Persons (PEP) Screening Country-level Value Analysis
  1. 7.1 Global Politically Exposed Persons (PEP) Screening Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Politically Exposed Persons (PEP) Screening Sales Value by Country (2021-2032)
  3. 7.2.1 Global Politically Exposed Persons (PEP) Screening Sales Value by Country (2021-2026)
  4. 7.2.2 Global Politically Exposed Persons (PEP) Screening Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Politically Exposed Persons (PEP) Screening Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Politically Exposed Persons (PEP) Screening Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Politically Exposed Persons (PEP) Screening Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 IDnow
  2. 8.1.1 IDnow Company Information
  3. 8.1.2 IDnow Business Overview
  4. 8.1.3 IDnow Politically Exposed Persons (PEP) Screening Revenue and Gross Margin (2021-2026)
  5. 8.1.4 IDnow Politically Exposed Persons (PEP) Screening Product Portfolio
  6. 8.1.5 IDnow Recent Developments
  7. 8.2 Jumio
  8. 8.2.1 Jumio Company Information
  9. 8.2.2 Jumio Business Overview
  10. 8.2.3 Jumio Politically Exposed Persons (PEP) Screening Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Jumio Politically Exposed Persons (PEP) Screening Product Portfolio
  12. 8.2.5 Jumio Recent Developments
  13. 8.3 Persona
  14. 8.3.1 Persona Company Information
  15. 8.3.2 Persona Business Overview
  16. 8.3.3 Persona Politically Exposed Persons (PEP) Screening Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Persona Politically Exposed Persons (PEP) Screening Product Portfolio
  18. 8.3.5 Persona Recent Developments
  19. 8.4 Entrust
  20. 8.4.1 Entrust Company Information
  21. 8.4.2 Entrust Business Overview
  22. 8.4.3 Entrust Politically Exposed Persons (PEP) Screening Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Entrust Politically Exposed Persons (PEP) Screening Product Portfolio
  24. 8.4.5 Entrust Recent Developments
  25. 8.5 Smile ID
  26. 8.5.1 Smile ID Company Information
  27. 8.5.2 Smile ID Business Overview
  28. 8.5.3 Smile ID Politically Exposed Persons (PEP) Screening Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Smile ID Politically Exposed Persons (PEP) Screening Product Portfolio
  30. 8.5.5 Smile ID Recent Developments
  31. 8.6 Veriff
  32. 8.6.1 Veriff Company Information
  33. 8.6.2 Veriff Business Overview
  34. 8.6.3 Veriff Politically Exposed Persons (PEP) Screening Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Veriff Politically Exposed Persons (PEP) Screening Product Portfolio
  36. 8.6.5 Veriff Recent Developments
  37. 8.7 Trulioo
  38. 8.7.1 Trulioo Company Information
  39. 8.7.2 Trulioo Business Overview
  40. 8.7.3 Trulioo Politically Exposed Persons (PEP) Screening Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Trulioo Politically Exposed Persons (PEP) Screening Product Portfolio
  42. 8.7.5 Trulioo Recent Developments
  43. 8.8 GBG Plc
  44. 8.8.1 GBG Plc Company Information
  45. 8.8.2 GBG Plc Business Overview
  46. 8.8.3 GBG Plc Politically Exposed Persons (PEP) Screening Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GBG Plc Politically Exposed Persons (PEP) Screening Product Portfolio
  48. 8.8.5 GBG Plc Recent Developments
  49. 8.9 Sumsub
  50. 8.9.1 Sumsub Company Information
  51. 8.9.2 Sumsub Business Overview
  52. 8.9.3 Sumsub Politically Exposed Persons (PEP) Screening Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sumsub Politically Exposed Persons (PEP) Screening Product Portfolio
  54. 8.9.5 Sumsub Recent Developments
  55. 8.10 Ondato
  56. 8.10.1 Ondato Company Information
  57. 8.10.2 Ondato Business Overview
  58. 8.10.3 Ondato Politically Exposed Persons (PEP) Screening Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Ondato Politically Exposed Persons (PEP) Screening Product Portfolio
  60. 8.10.5 Ondato Recent Developments
  61. 8.11 NameScan
  62. 8.11.1 NameScan Company Information
  63. 8.11.2 NameScan Business Overview
  64. 8.11.3 NameScan Politically Exposed Persons (PEP) Screening Revenue and Gross Margin (2021-2026)
  65. 8.11.4 NameScan Politically Exposed Persons (PEP) Screening Product Portfolio
  66. 8.11.5 NameScan Recent Developments
  67. 8.12 Castellum.AI
  68. 8.12.1 Castellum.AI Company Information
  69. 8.12.2 Castellum.AI Business Overview
  70. 8.12.3 Castellum.AI Politically Exposed Persons (PEP) Screening Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Castellum.AI Politically Exposed Persons (PEP) Screening Product Portfolio
  72. 8.12.5 Castellum.AI Recent Developments
  73. 8.13 Dotfile
  74. 8.13.1 Dotfile Company Information
  75. 8.13.2 Dotfile Business Overview
  76. 8.13.3 Dotfile Politically Exposed Persons (PEP) Screening Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Dotfile Politically Exposed Persons (PEP) Screening Product Portfolio
  78. 8.13.5 Dotfile Recent Developments
  79. 8.14 RELX (LexisNexis)
  80. 8.14.1 RELX (LexisNexis) Company Information
  81. 8.14.2 RELX (LexisNexis) Business Overview
  82. 8.14.3 RELX (LexisNexis) Politically Exposed Persons (PEP) Screening Revenue and Gross Margin (2021-2026)
  83. 8.14.4 RELX (LexisNexis) Politically Exposed Persons (PEP) Screening Product Portfolio
  84. 8.14.5 RELX (LexisNexis) Recent Developments
  85. 8.15 Owlin
  86. 8.15.1 Owlin Company Information
  87. 8.15.2 Owlin Business Overview
  88. 8.15.3 Owlin Politically Exposed Persons (PEP) Screening Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Owlin Politically Exposed Persons (PEP) Screening Product Portfolio
  90. 8.15.5 Owlin Recent Developments
  91. 8.16 Dilisense GmbH
  92. 8.16.1 Dilisense GmbH Company Information
  93. 8.16.2 Dilisense GmbH Business Overview
  94. 8.16.3 Dilisense GmbH Politically Exposed Persons (PEP) Screening Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Dilisense GmbH Politically Exposed Persons (PEP) Screening Product Portfolio
  96. 8.16.5 Dilisense GmbH Recent Developments
  97. 8.17 Fenergo
  98. 8.17.1 Fenergo Company Information
  99. 8.17.2 Fenergo Business Overview
  100. 8.17.3 Fenergo Politically Exposed Persons (PEP) Screening Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Fenergo Politically Exposed Persons (PEP) Screening Product Portfolio
  102. 8.17.5 Fenergo Recent Developments
  103. 8.18 Thirdfort
  104. 8.18.1 Thirdfort Company Information
  105. 8.18.2 Thirdfort Business Overview
  106. 8.18.3 Thirdfort Politically Exposed Persons (PEP) Screening Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Thirdfort Politically Exposed Persons (PEP) Screening Product Portfolio
  108. 8.18.5 Thirdfort Recent Developments
  109. 8.19 Experian
  110. 8.19.1 Experian Company Information
  111. 8.19.2 Experian Business Overview
  112. 8.19.3 Experian Politically Exposed Persons (PEP) Screening Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Experian Politically Exposed Persons (PEP) Screening Product Portfolio
  114. 8.19.5 Experian Recent Developments
  115. 8.20 AU10TIX
  116. 8.20.1 AU10TIX Company Information
  117. 8.20.2 AU10TIX Business Overview
  118. 8.20.3 AU10TIX Politically Exposed Persons (PEP) Screening Revenue and Gross Margin (2021-2026)
  119. 8.20.4 AU10TIX Politically Exposed Persons (PEP) Screening Product Portfolio
  120. 8.20.5 AU10TIX Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst